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Abstract
Objective: Aging is associated with impaired insulin sensitivity and increased prevalence of type 
2 diabetes. However, it remains unclear whether aging-associated insulin resistance is due to 
increased adiposity or other age-related factors. To address this question, we investigated the 
impact of aging on insulin sensitivity independently of changes in body composition.
Methods: Cohorts of mice at 4–8 months (‘young’) and 18–27 months (‘aged’) of age exhibiting 
similar body composition were characterized for glucose metabolism on chow and high-fat diets. 
Insulin sensitivity was assessed by hyperinsulinemic-euglycemic clamp analyses. The relationship 
between aging and insulin resistance in humans was investigated in 1,250 non-diabetic Mexican-
Americans who underwent hyperinsulinemic-euglycemic clamps.
Results: In mice with similar body composition, age had no detrimental effect on plasma glucose 
and insulin levels. While aging did not diminish glucose tolerance, hyperinsulinemiceuglycemic 
clamps demonstrated impaired insulin sensitivity and reduced insulin clearance in aged mice on 
chow and high-fat diets. Consistent with results in the mouse, age remained an independent 
determinant of insulin resistance after adjustment for body composition in Mexican-American 
males.
Conclusions: This study demonstrates that in addition to altered body composition, adiposity-
independent mechanisms also contribute to aging-associated insulin resistance in mice and 
humans.
Keywords
aging; insulin sensitivity; insulin clearance
Introduction
The negative influence of aging on insulin sensitivity and the prevalence of type 2 diabetes 
(T2D) has long been recognized (1). However, the pathogenetic mechanisms responsible for 
the age-related deterioration of glucose metabolism remain incompletely understood (2, 3). 
A principal difficulty is that aging is associated with several adverse physiological changes 
(e.g. altered body composition, reduced physical activity, sarcopenia, inflammation), which 
makes it difficult to decipher the role of age-related comorbidities. For example, whereas 
aging-associated declines in glucose tolerance and insulin sensitivity are well documented in 
the mouse, previous reports are based on comparisons between young and old mice that 
exhibit different body compositions (4, 5, 6, 7). Thus, while the metabolic impact of age-
related changes in body composition is well established (8), the potential contribution of 
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adiposity-independent mechanisms to aging-associated insulin resistance remains 
unexplored.
A substantial body of evidence indicates that insulin sensitivity also declines with advanced 
age in humans (9, 10, 11, 12). To discriminate between the effects of age versus aging-
associated changes in body composition, previous studies employed young and elderly 
cohorts matched for adiposity, or adjusted for this trait in population-based cohorts. 
Investigations in predominantly non-Hispanic white cohorts consistently failed to 
demonstrate an effect of aging on insulin sensitivity after adjustment for altered body 
composition suggesting that increased adiposity is responsible for age-associated 
deterioration of glucose tolerance in this population (11, 12, 13, 14, 15, 16). In contrast, in a 
Japanese population-based cohort, age remained positively correlated with insulin resistance 
even after adjusting for fat content (17). Remarkably, adjustment for adiposity revealed age-
related improvement in insulin sensitivity in other cohorts with predominantly African-
American participants (18, 19, 20). Taken together, these observations suggest that genetic 
and/or other ethnicity-specific determinants may play a role in age-related changes in insulin 
action and raise the possibility that impaired glucose homeostasis associated with aging may 
have different etiologies in different populations.
Based on the established role of increased adiposity in impaired insulin sensitivity, we 
hypothesized that insulin resistance associated with aging is due to age-related changes in 
body composition. In the present study, we explored this hypothesis in mouse and human 
subjects. In mice, we assessed insulin sensitivity in young and aged animals exhibiting 
similar body composition. In human studies, we addressed this question in Mexican-
Americans, a population in which the metabolic impact of aging has not been investigated 
before despite strong predisposition to diabetes (21).
Methods
Animals
Young and aged male C57BL/6J mice were purchased from The Jackson Laboratory (Bar 
Harbor, ME) at 2–3 and 12 months of age, respectively, and maintained at Cedars-Sinai 
Medical Center until analysis at ages indicated in the figure legends. We used several 
approaches to ensure that only apparently healthy aged mice were included in our study. 
First, body weights were measured biweekly and mice showing weight loss at two 
successive time points were excluded from phenotyping. Second, complete blood cell count 
was evaluated with a HEMAVET 950 FS counter (Drew Scientific, FL) to identify and 
exclude mice with lymphomas, a prevalent neoplasm in aging C57BL/6 mice (22). Finally, 
after phenotypic characterization, aged mice underwent necropsy and mice with visible 
tumors and enlarged organs were excluded from analysis. Animals were maintained under 
specific pathogen-free (SPF) conditions on a 14-h light/10-h dark cycle and fed ad libitum 
Laboratory Rodent Diet 5053 (LabDiet) or a high-fat (HF) diet (D12492; 60 kcal% from 
lard; Research Diets) for 9 weeks with free access to water. Experimental procedures were 
approved by the Institutional Animal Care and Use Committees at Cedars-Sinai Medical 
Center, Western University, University of Massachusetts and Vanderbilt University.
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Mouse phenotyping
Body composition was determined by quantitative magnetic resonance analysis (EchoMRI, 
TX). Blood glucose concentrations were measured with a OneTouch portable glucose meter 
(LifeScan, CA). Plasma insulin and C-peptide were assayed by ELISA (ALPCO, NH). In 
glucose tolerance tests (GTT), overnight fasted mice were retro-orbitally injected with 1.5 
g/kg (chow diet) or 1 g/kg (HF diet) glucose followed by blood glucose measurements. 
Insulin tolerance tests (ITT) were performed in ad libitum fed mice by retro-orbital injection 
of 0.8 U/kg (chow diet) or 1.2 U/kg (HF diet) insulin followed by blood glucose 
measurements. Hyperinsulinemic-euglycemic clamping of mice was performed at the 
National Mouse Metabolic Phenotyping Centers (MMPC) at the University of 
Massachusetts Medical School and Vanderbilt University (Supplemental Material). The 
metabolic clearance rate of insulin (MCRI) was calculated as insulin infusion rate divided by 
the mean plasma insulin concentration at steady state (23). The calculation of MCRI 
assumes that endogenous insulin secretion is completely suppressed in the setting of 
hyperinsulinemic clamp, as has been demonstrated in several species (24, 25, 26).
Human study subjects
The current study was conducted in 1,250 non-diabetic subjects from two independent 
family-based cohorts recruited from the Los Angeles area, the Hypertension-Insulin 
Resistance (HTNIR) and the Mexican-American Coronary Artery Disease (MACAD) 
cohorts. HTN-IR consists of Los Angeles Hispanic-American families ascertained via a 
proband with essential hypertension (27). MACAD participants were drawn from adult 
offspring of probands with coronary artery disease and their spouses (28). Participants were 
free of major medical illness and none were taking glucocorticoids or antihyperglycemic 
agents that could affect glucose homeostasis when they were phenotyped. All subjects gave 
written informed consent prior to participation.
Human phenotyping
We studied 579 subjects from HTN-IR and 671 MACAD participants who had undergone 
phenotyping with the hyperinsulinemic-euglycemic clamp as described previously (29). The 
glucose infusion rate (M value) during the last 30 minutes of steady-state glucose and insulin 
levels during the clamp reflects glucose uptake by all tissues of the body (mainly insulin-
mediated glucose uptake in muscle) and is directly correlated with tissue insulin sensitivity 
(30). The insulin sensitivity index (M/I) was calculated as M divided by the steady state 
plasma insulin level (I). The MCRI was calculated as the insulin infusion rate divided by the 
insulin concentration during the steady state of the euglycemic clamp, as previously 
described (30, 31). Body adiposity index (BAI) was calculated as (hip circumference in 
centimeters)/(height in meters)1.5-18) (32). BMI was calculated as weight in kilograms 
divided by height in meters squared. Fasting plasma C-reactive protein (CRP) concentration 
was measured as a proxy of inflammation. Physical activity was assessed as described in 
Supplemental Information. All studies were approved by Human Subjects Protection 
Institutional Review Boards at UCLA, the University of Southern California and Cedars-
Sinai Medical Center.
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Statistical analysis
In the mouse data, normally distributed values are expressed as mean ± SEM and non-
normally distributed values are represented by the median and interquartile range (IQR). 
Comparisons between two groups were performed by Student’s t-test or Mann-Whitney U 
test. GTT and ITT results were analyzed by 2-way repeated measures ANOVA and Holm-
Sidak post hoc tests. ANOVA and correlation analyses of non-normally distributed variables 
were performed after transformation or on ranks. Outlier data points were defined as those 
falling outside 2xIQR. Based on this criterion, 2 extreme values were excluded from analysis 
in the entire study (1 young and 1 aged mouse in Figure 2G). Differences at p<0.05 were 
considered statistically significant.
In the human data, log-transformed (BMI, CRP, fasting glucose, fasting insulin) or square 
root‐transformed (M value, M/I, MCRI, PAS) trait values were used to normalize the 
distribution for statistical analyses. Generalized estimating equations (GEE) were used to 
assess the relationships between pairs of traits (univariate analyses) or joint effects of 
multiple traits (multivariate analyses) on M, M/I, or MCRI, adjusting for familial 
relationships. The weighted GEE1 (35) was computed assuming an exchangeable correlation 
structure and using the sandwich estimator of the variance to account for familial correlation 
present in family data. GEE was used to derive standardized regression coefficients, which 
in any one regression equation are measured on the same scale, with a mean of zero and a 
standard deviation of one. They are then directly comparable to one another, with the largest 
coefficient indicating which independent variable has the greatest association with the 
dependent variable.
Results
Aging reduces insulin sensitivity and clearance in lean mice independent of body 
composition
Several previous studies investigating the metabolic impact of aging documented reduced 
glucose tolerance and insulin resistance in old mice (14–26 months of age) relative to young 
(1–3 months) mice (4, 5, 6, 7). However, as body fat content increases during the first few 
months of life, these studies were confounded with different body compositions in old vs 
young mice (4, 5, 6, 7). Thus, the potential adiposity-independent metabolic effects of aging 
remain unknown. As body weight and adiposity reach a plateau in mature adult (~4 months) 
mice (36, 37), we reasoned that using mouse cohorts beyond this age would allow metabolic 
characterization without the confounding effects of altered body composition. Indeed, 
mature adult C57BL/6J mice at 4–5 months of age (from here on referred to as ‘young’) 
exhibited body weight, lean mass, fat mass and percent fat content that were 
indistinguishable from 18–21-month-old (‘aged’) mice (Fig. 1A). Furthermore, young and 
aged mice maintained similar fasting and ad libitum fed glucose and insulin levels (Fig. 1B 
and 1C). Intravenous glucose tolerance tests (GTT) revealed that aged mice were slightly, 
but significantly more glucose tolerant than young mice (Fig. 1D). This was due, at least in 
part, to increased glucose-stimulated insulin secretion in aged mice, as both insulin and C-
peptide levels were elevated in this group 15 min after glucose injection (Fig. 1E and 1F), 
consistent with previous studies (38). In insulin tolerance tests (ITT), young and aged mice 
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demonstrated similar glucose response to intravenously-injected insulin (Fig. 1G). To 
confirm these results, we characterized a second group of young (6-month-old) and aged 
(25-month-old) mice with similar body composition (Fig. S1A). Consistent with results 
obtained in the initial cohort, aged mice exhibited improved glucose tolerance (Fig. S1B), 
but unchanged insulin tolerance (Fig. S1C) relative to young mice.
We further investigated the metabolic impact of aging by assessing glucose homeostasis in a 
third cohort of young (8-month-old) and aged (27-month-old) male mice by 
hyperinsulinemiceuglycemic clamp analyses. Body weight and composition, fasting plasma 
glucose and insulin levels, and the rate of hepatic glucose production were indistinguishable 
between young and aged mice in the basal state (Table S1). During the clamp, no significant 
differences were observed in steady-state glucose levels, glucose infusion rate (GIR), whole 
body glucose turnover, suppression of hepatic glucose production, and glucose uptake into 
muscle and adipose tissue (Fig. 2A–E, Table S1). However, despite identical rates of insulin 
infusion, aged mice exhibited elevated plasma insulin levels (Fig. 2F) and a lower rate of 
insulin clearance from the circulation (Fig. 2G). Based on the observation of similar insulin 
action despite higher insulin levels in aged animals, we conclude that aging is associated 
with increased hepatic, muscle and adipose insulin resistance in male mice independent of 
changes in adiposity.
Aging reduces insulin sensitivity and clearance in diet-induced obese mice independent of 
body composition
The results in lean mice prompted us to investigate whether diet-induced metabolic stress 
may exacerbate aging-related insulin resistance. To test this hypothesis, we assessed the 
impact of aging on glucose homeostasis in the context of diet-induced obesity by 
characterizing young (6-month-old) and aged (24-month-old) male C57BL/6J mice fed a HF 
diet (60 kcal% from fat) for 9 weeks. At the time of metabolic analysis young and aged mice 
had similar body weights and composition (Fig. 3A). Unexpectedly, aged mice maintained 
lower fasting and fed glucose levels (Fig. 3B) despite similar plasma insulin concentrations 
(Fig. 3C). Consistent with results obtained in lean mice, obese aged mice also demonstrated 
improved glucose tolerance relative to young animals (Fig. 3D). Furthermore, assessment of 
insulin tolerance by ITT revealed that exogenous insulin had a greater glucose-suppressing 
effect in aged mice at later time-points of the assay, although the difference in areas under 
the curve did not reach statistical significance (Fig. 3E).
To evaluate insulin sensitivity directly, we performed hyperinsulinemic-euglycemic clamp 
experiments. Under basal conditions, body weight and composition, insulin levels and the 
rate of hepatic glucose production were similar in young and aged mice, whereas the latter 
exhibited significantly lower fasting glucose levels (Table S2). During the clamp, steady-
state glucose levels and GIR were similar in obese young and aged mice (Fig. 2H–I, Table 
S2). However, obese aged mice maintained significantly higher insulin levels (Fig. 2M) and 
demonstrated reduced insulin clearance (Fig. 2N), consistent with results obtained in lean 
mice. Despite elevated plasma insulin concentration in aged mice, whole body glucose 
turnover and glucose uptake in muscle and adipose were similar between the groups. 
whereas insulin-mediated suppression of hepatic glucose production was significantly 
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greater in aged mice (Fig. 2J–L, Table S2,). Taken together, our results indicate that in the 
metabolic context of diet-induced obesity, aging is associated with improved glucose 
tolerance, reduced insulin clearance, and impaired muscle and adipose insulin sensitivity in 
male mice.
Aging reduces insulin sensitivity in Mexican-American males independent of body 
composition and inflammation
To explore the relationship between age, insulin resistance, insulin clearance and adiposity 
in humans, we performed correlation analyses in a Mexican-American cohort of 1,250 
participants free of diabetes and overt metabolic disease. The age range of the cohort is 7 
decades (16–87 years) and insulin sensitivity has been assessed by hyperinsulinemic-
euglycemic clamp. Univariate correlation analyses revealed aging-associated impairment in 
glucose homeostasis including elevated fasting plasma glucose levels, reduced insulin 
sensitivity (M and M/I) and decreased MCRI (Table 1). To assess body composition, we 
used BMI and BAI, an alternative surrogate measure of fat content more closely tracking 
percent fat content in Mexican-Americans (32). Both BMI and BAI exhibited strong positive 
correlations with age indicating fat accumulation during aging in this population (Table 1). 
Similarly, aging was also associated with increased plasma CRP level, a measure of systemic 
inflammation (Table 1). Physical activity showed no correlation with age in this cohort 
(Table 1).
Sex-specific analysis demonstrated significant negative correlations between age and insulin 
action in both males and females with notably weaker effects in the latter (Table 2, Fig. S2). 
To separate the contributions of age from other factors affecting insulin action, we 
performed multivariate correlation analyses with measures of insulin sensitivity as 
dependent variables and age, body composition and plasma CRP concentration as 
independent variables. In males, age remained strongly correlated with insulin resistance 
even after adjustment for changes in body composition and CRP (Table 2). In contrast, 
controlling for adiposity reduced or abolished the correlation between age and insulin action 
in females, depending on the measure of insulin sensitivity used (Table 2). As expected, 
BMI/BAI and CRP levels showed strong negative correlations with measures of insulin 
sensitivity independent of the effect of age in both sexes (Fig. S2, Tables 3 and 4). Taken 
together, these results demonstrate an age-dependent decline of insulin sensitivity in 
Mexican-American males and females. In females, this is principally due to aging-associated 
increases in fat mass, whereas in males age remains an independent determinant of insulin 
resistance even after adjusting for measures of body composition and inflammation.
Sex-specific analysis of insulin clearance revealed that the age-related decline observed in 
the full cohort (Table 1) was exclusively due to males, as significant correlation between age 
and MCRI could not be detected in females (Table 5). Furthermore, multivariate analysis 
indicated that the aging-associated decrease of insulin clearance in males was due to 
increased body fat content (Table 5).
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Discussion
The association of aging with impaired insulin resistance has been well established in mice 
(4, 5, 6, 7). However, as body composition changes with normal aging, previous studies have 
been unable to disentangle the effects of adiposity from adiposity-independent mechanisms. 
In the present study, we addressed this problem by characterizing mice of different age, but 
similar body composition. We took advantage of the fact that body weight and fat content in 
mice reach a plateau at the mature adult stage (~4 months) and remain unchanged thereafter 
(36, 37). Thus, using ‘young’ mouse cohorts at >4 months of age allowed us to investigate 
the adiposity-independent effects of aging on glucose metabolism. Our use of aged mice was 
guided by two considerations. First, we used cohorts spanning a wide range of ages (18–27 
months) for primary and replication experiments to allow generalization of the results to all 
mice of advanced age. Moreover, to ensure that our results reflect the effects of healthy 
aging and not age-related diseases, a multipronged approach (see Methods) was employed to 
identify and eliminate sick mice from experimental cohorts.
When mice with similar body compositions were compared, advanced age had no 
detrimental impact on static (i.e. plasma glucose and insulin levels) or dynamic measures 
(i.e. GTT, ITT) of glucose metabolism. In fact, we found that aged mice exhibited slightly 
improved glucose tolerance, an observation that was replicated in three independent mouse 
cohorts on two different diets. While this observation was initially unexpected, improved 
glucose tolerance in aging C57BL/6J mice has also been reported previously, consistent with 
our results (38). Importantly and similar to the present work, Leiter et al. used ‘young’ mice 
at the relatively advanced age of 4.5- to 5 months, which likely diminished differences in 
body composition between young and old mice, although adiposity was not directly assessed 
in the earlier study (38). It has also been demonstrated that aging is associated with 
increased pancreatic islet area and insulin content, whereas β-cell sensitivity to glucose 
remained unaffected (38). These results are consistent with our observation of elevated C-
peptide levels after glucose administration in aged mice and suggest that elevated glucose-
stimulated insulin secretion contributes to their improved glucose tolerance. Another factor 
likely contributing to improved glucose tolerance in aged mice is reduced insulin clearance, 
which we demonstrated in hyperinsulinemic clamp experiments. Thus, we hypothesize that 
the interaction between increased production and reduced clearance of insulin may explain 
the apparent over-compensation for insulin resistance in aged mice. In conclusion, while 
glucose intolerance is a hallmark of aging (6, 39), our results demonstrate that this is not an 
inevitable consequence of advanced age, but most likely due to increased adiposity 
associated with aging in C57BL/6J mice.
We assessed the impact of aging on insulin sensitivity by hyperinsulinemic-euglycemic 
clamps in young and aged mice of similar body compositions. Despite similar rates of 
insulin infusion, aged mice exhibited significantly higher plasma insulin concentration 
during the clamp. This observation held true for both lean mice maintained on a normal 
chow diet and diet-induced obese mice on a HF-diet. In lean mice, measures of whole-body 
and tissue insulin action were similar in young and aged animals. Together with elevated 
insulin levels in the latter, these data demonstrate that aging has adiposity-independent 
effects on insulin sensitivity in C57BL/6J mice.
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We initially hypothesized that the metabolic stress associated with HF diet feeding would 
exacerbate aging-related impairments in glucose homeostasis. However, our results do not 
support this hypothesis. In fact, obese aged mice maintained lower basal glucose levels and 
exhibited improved glucose tolerance relative to their young counterparts. Furthermore, we 
unexpectedly found that aging impacted tissues differently in diet-induced obese mice. 
Consistent with observations in lean mice, despite elevated clamp insulin levels, insulin 
action was similar in muscle and adipose tissues of young and aged animals indicating 
relative insulin resistance in the latter. In contrast, suppression of hepatic glucose production 
was substantially stronger in obese aged versus young mice. Although the concurrent 
elevation of insulin levels complicates the interpretation of this observation, our results 
suggest that hepatic insulin sensitivity may not be adversely impacted by age in the context 
of diet-induced obesity. Consistent with this conclusion, aging has also been associated with 
improved hepatic insulin action in humans in a handful of studies where hepatic glucose 
production was determined (18, 40).
Most previous human studies focusing predominantly on non-Hispanic white populations 
led to the consensus view that aging-associated insulin resistance is due to age-related 
increase in adiposity (11, 12, 13, 14, 15, 16, 18). In the current study, we addressed this issue 
in a cohort of Mexican-American subjects. Consistent with previous reports, insulin 
sensitivity declined with age in both sexes. However, the relative contribution of increased 
adiposity to aging-associated insulin resistance was different between the sexes. In Mexican-
American females, diminished insulin action was exclusively due to increased adiposity, in 
line with results in Caucasians (11, 12, 13, 14, 15, 16, 18). In contrast, while elevated 
adiposity was a major determinant of declining insulin action in males, too, aging also 
contributed to insulin resistance independent of changes in body composition. A similar 
conclusion was reached in a recent study in Japanese subjects (17). In addition to adiposity, 
we also considered age-related changes in physical activity and inflammation as potential 
mechanisms underlying aging-associated insulin resistance in Mexican-American males. A 
role for altered physical activity could be excluded, as the physical activity score did not 
change with age in this cohort. Moreover, although increased CRP levels were associated 
with aging, adjusting for CRP failed to diminish the correlation between age and insulin 
resistance. Taken together, these results demonstrate that in addition to the established role 
of increased adiposity in insulin resistance, aging also impairs insulin sensitivity through 
mechanisms that are independent of body composition, inflammation and physical activity. 
Furthermore, our study in Mexican-Americans highlights the previously underappreciated 
role of sex and ethnicity in aging-associated insulin resistance.
Previous studies investigating the impact of aging on insulin clearance yielded mixed results 
(11, 41, 42, 43). Here we report consistent age-related declines in the rate of insulin removal 
from the circulation in mouse and human subjects. Nonetheless, the underlying mechanisms 
appear to be different in the two species. Whereas increased adiposity is the main driver of 
reduced insulin turnover in aging Mexican-Americans, diminished insulin clearance in aged 
C57BL/6J mice is independent of body composition. This observation is consistent with the 
recent demonstration of age-related loss of hepatic endothelial fenestrations and diminished 
insulin uptake associated with reduced insulin clearance in aged mice and rats (44). Our 
results also raise the question whether age-related changes in insulin clearance are the 
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consequence of insulin resistance or other aspects of aging. As aging is associated with 
impaired insulin sensitivity in both Mexican-Americans and the mouse model we used, 
further studies will be required to discriminate between these possibilities.
Although we conclusively demonstrated the contribution of adiposity-independent processes 
in the development of aging-associated insulin resistance, a limitation of our mouse studies 
is that the underlying mechanisms have not been identified. Decreased physical activity, 
increased systemic inflammation, elevated intramuscular lipid content and altered body fat 
distribution (i.e. visceral vs subcutaneous) represent potential mechanisms to account for 
reduced insulin sensitivity in aged mice and will need to be investigated in future studies. 
Nonetheless, the role of physical activity and inflammation was addressed in our human 
study, which suggested that neither of these factors explain the effect of aging on insulin 
resistance. Evaluation of additional mechanisms awaits further human studies. Our results in 
the Mexican-American cohort highlight the impact of sex on insulin resistance, as age was 
an adiposity-independent contributor to this trait only in men, but not women. As our animal 
study was limited to the characterization of male C57BL/6J mice, future work involving 
females and additional mouse strains is warranted to further investigate the role of sex and 
genetic determinants in age-related changes in insulin sensitivity.
In summary, the present study provides evidence in mouse and human populations that aging 
impairs insulin sensitivity independently of altered body composition. Based on the analysis 
of a Mexican-American cohort, this conclusion contrasts with previous results obtained in 
non-Hispanic white populations and suggests a role for genetic factors in age-related 
metabolic dysfunction. Consistent with a previous report (45), an intriguing possibility 
raised by the present study is that the mechanisms of obesity- and aging-associated insulin 
resistance may be distinct, which may have therapeutic implications for the treatment of 
T2D in the aging population. As demonstrated here, male C57BL/6J mice represent a 
suitable animal model to investigate the molecular mechanisms underlying adiposity-
independent effects of aging on insulin resistance.
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Importance of this study:
• Aging is associated with increased adiposity and impaired insulin sensitivity.
• Whereas body composition is a known determinant of insulin sensitivity, it 
remains unclear whether adiposity-independent factors also contribute to 
aging-associated insulin resistance.
• This study demonstrates the contribution of adiposity-independent factors in 
the development of aging-associated insulin resistance in mice and humans.
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Figure 1 –. 
(A) Body weight (BW) and composition of young (4–5 months) and aged (18–21 months) 
mice (n = 9 mice per group). Vertical axis shows mass in grams for BW, Lean and Fat, or 
body composition as percentage of fat for Fat%. (B) Blood glucose levels in overnight fasted 
and ad libitum fed mice (n = 9 mice per group). (C) Plasma insulin levels in overnight fasted 
and ad libitum fed mice (horizontal bars represent median, n = 7 fasted mice per group and 
9–10 fed mice per group). (D) Glucose tolerance test (n = 9 mice per group). *, p < 0.05; 
comparison by 2-way repeated measures ANOVA (left panel) or Student’s t test (right 
panel). (E) Plasma insulin levels 15 minutes after glucose injection (horizontal bars 
represent mean, n = 6 young + 7 aged mice). *, p < 0.05; comparison by Student’s t-test. (F) 
Plasma C-peptide levels 15 minutes after glucose injection (horizontal bars indicate mean, n 
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= 6 young + 7 aged mice). *, p < 0.05; comparison by Student’s t-test. (G) Insulin tolerance 
test (n = 9 mice per group). Data are presented as mean ± SEM unless stated otherwise.
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Figure 2 –. 
(A-G) Hyperinsulinemic-euglycemic clamp results in young (n = 12; 8 months of age) and 
aged (n = 11; 27 months of age) male C57BL/6J mice on chow diet. (H-N) 
Hyperinsulinemic-euglycemic clamp results in young (n = 7; 6 months of age) and aged (n = 
5; 24 months of age) diet-induced obese male C57BL/6J mice. (A and H) Blood glucose 
levels. (B and I) Glucose infusion rate (GIR) during the clamp (left panel) and at steady state 
(80–120 min; right panel). P value corresponds to the effect of ‘Age’ factor in 2-way 
repeated measures ANOVA. (C and J) Suppression of hepatic glucose production. (D and 
K) Skeletal muscle glucose uptake. (E and L) Adipose tissue glucose uptake. (F and M) 
Plasma insulin levels during the final 20 min (100–120 min) of the clamp. (G and N) 
Metabolic clearance rate of insulin (MCRI) during the final 20 min of the clamp. (A-E and 
H-L) Data are presented as mean ± SEM. *, p < 0.05; comparison by Student’s t-test. (F-G 
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and M-N) Horizontal bars represent median. *, p < 0.05; comparison by Mann-Whitney U 
test.
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Figure 3 –. 
(A) Body weight (BW) and composition of young (6 months) and aged (24 months) mice (n 
= 8 mice per group) after 9 weeks of HF diet feeding. Vertical axis shows mass in grams for 
BW, Lean and Fat, or body composition as percentage of fat for Fat%. (B) Blood glucose 
levels in 5-hour fasted (n = 8 young + 6 aged mice) and ad libitum fed (n = 8 mice per 
group) mice. *, p < 0.05; comparison by Student’s t-test. (C) Plasma insulin levels in 5-h 
fasted (n = 8 young + 7 aged mice) and ad libitum fed mice (n = 7 young + 6 aged mice). 
Horizontal bars represent median. (D) Glucose tolerance test (n = 8 mice per group). *, p < 
0.05; comparison by 2-way repeated measures ANOVA (left panel) or Student’s t test (right 
Ehrhardt et al. Page 19
Obesity (Silver Spring). Author manuscript; available in PMC 2020 March 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
panel). (E) Insulin tolerance test (n = 8 mice per group). *, p < 0.05; comparison by 2-way 
repeated measures ANOVA.
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Table 1.
Clinical characteristics and their correlation with age in Mexican-Americans
n Median IQR r p
Age [years] 1250 34 15
BMI [kg/m2] 1250 28.2 6.5 0.188 <0.0001
BAI [%] 1250 31.8 8.7 0.199 <0.0001
Fasting plasma glucose [mg/dl] 1246 92.0 12.0 0.213 <0.0001
Fasting plasma insulin [μU/ml] 1194 12.0 8.2 0.017 0.568
M [mg/min/m2] 1250 223 150 −0.205 <0.0001
M/I [mg × ml/min/m2/mU] 1191 1.72 1.43 −0.192 <0.0001
MCRI [ml/m2/min] 1191 459 135 −0.062 0.020
CRP [mg/l] 960 1.45 2.33 0.175 <0.0001
PAS [kcal/kg/week] 636 174 161 −0.059 0.140
The cohort consists of 42.8% males and 57.2% females. IQR, interquartile range; BMI, body mass index; BAI, body adiposity index; M, glucose 
disposal rate in the final 30 min of euglycemic clamp normalized by body surface area; M/I, M value divided by steady-state insulin concentration 
during the clamp; MCRI, metabolic clearance rate of insulin; CRP, C-reactive protein; PAS, physical activity score. p<0.05 values appear in bold.
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Table 5.
Multivariate correlations between insulin clearance and age in Mexican-Americans
Males Females
Independent variables n β p n β p
Age 505 −0.104 0.008 686 −0.033 0.335
Age, BMI 505 −0.068 0.112 686 0.029 0.422
Age, BAI 505 −0.069 0.107 686 0.023 0.527
Age, BMI, CRP 378 −0.089 0.083 531 0.019 0.638
Age, BAI, CRP 378 −0.086 0.091 531 0.020 0.622
MCRI is the dependent variable; Age and measures of body composition are independent variables. Standardized coefficients (β) and p values for 
Age are shown. MCRI was square root-, BMI and CRP were log-transformed before analysis. n, number of subjects. p<0.05 values appear in bold.
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